Quantcast
Last updated on April 16, 2014 at 14:14 EDT

Latest Wolfram Samlowski Stories

2013-06-02 23:01:05

A promising, new cancer immunotherapy combination treatment showing long term survival for patients with metastatic melanoma was highlighted today at the American Society of Clinical Oncology Annual Meeting in Chicago. (PRWEB) June 02, 2013 A promising, new cancer immunotherapy combination treatment showing long term survival for patients with metastatic melanoma was highlighted today at the American Society of Clinical Oncology Annual Meeting in Chicago. Results form a phase II study...

2013-02-26 08:28:10

Thought-Leaders to Steer Development of the Company's ImmunoPulse Program SAN DIEGO, Feb. 26, 2013 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced the formation of a Melanoma Advisory Board (MAB) for the company's metastatic melanoma program. (Logo: http://photos.prnewswire.com/prnh/20120905/LA68078LOGO) Bringing together a group of...

2013-01-15 07:17:10

SAN DIEGO, Jan. 15, 2013 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced the company's upcoming milestones for 2013 at the Biotech Showcase conference held January 7-9 in San Francisco, CA. (Logo: http://photos.prnewswire.com/prnh/20120905/LA68078LOGO) "2012 marked a critical year for OncoSec," said Punit Dhillon, President and CEO. "We launched three...